Recursion Pharmaceuticals, Inc. (RXRX)
3.55
-0.26
(-6.70%)
USD |
NASDAQ |
Nov 10, 16:00
3.56
+0.01
(+0.28%)
After-Hours: 20:00
Recursion Pharmaceuticals Total Return Level : 3.55 for Nov. 10, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 10, 2026 | 3.55 |
| November 09, 2026 | 3.805 |
| November 06, 2026 | 3.52 |
| November 05, 2026 | 3.50 |
| November 04, 2026 | 3.88 |
| November 03, 2026 | 3.68 |
| November 02, 2026 | 3.83 |
| October 30, 2026 | 4.03 |
| October 29, 2026 | 4.24 |
| October 28, 2026 | 4.35 |
| October 27, 2026 | 4.05 |
| October 26, 2026 | 3.80 |
| October 23, 2026 | 3.70 |
| October 22, 2026 | 3.58 |
| October 21, 2026 | 3.64 |
| October 20, 2026 | 3.66 |
| October 19, 2026 | 3.61 |
| October 16, 2026 | 3.465 |
| October 15, 2026 | 4.16 |
| October 14, 2026 | 3.74 |
| October 13, 2026 | 3.835 |
| October 12, 2026 | 4.01 |
| October 09, 2026 | 4.36 |
| October 08, 2026 | 3.95 |
| October 07, 2026 | 4.27 |
| Date | Value |
|---|---|
| October 06, 2026 | 4.63 |
| October 05, 2026 | 4.78 |
| October 02, 2026 | 4.12 |
| October 01, 2026 | 4.07 |
| September 30, 2026 | 4.13 |
| September 29, 2026 | 4.03 |
| September 28, 2026 | 3.70 |
| September 25, 2026 | 3.74 |
| September 24, 2026 | 3.89 |
| September 23, 2026 | 3.70 |
| September 22, 2026 | 4.05 |
| September 21, 2026 | 3.97 |
| September 18, 2026 | 3.83 |
| September 17, 2026 | 3.54 |
| September 16, 2026 | 3.19 |
| September 15, 2026 | 3.24 |
| September 14, 2026 | 3.41 |
| September 11, 2026 | 3.20 |
| September 10, 2026 | 3.16 |
| September 09, 2026 | 3.215 |
| September 08, 2026 | 3.44 |
| September 04, 2026 | 3.63 |
| September 03, 2026 | 3.44 |
| September 02, 2026 | 3.38 |
| September 01, 2026 | 3.33 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Absci Corp. | 9.97 |
| Twist Bioscience Corp. | 132.13 |
| Editas Medicine, Inc. | 2.505 |
| Intellia Therapeutics, Inc. | 11.17 |
| Beam Therapeutics, Inc. | 25.15 |